Use the lowest fluence that produces the correct immediate endpoint—not the highest fluence the skin can tolerate. For Nevus of Ota treated with Q-switched lasers, immediate lesion whitening generally indicates effective melanosome disruption. In darker phototypes, especially Fitzpatrick IV–V, this endpoint is usually achieved with slightly lower fluence—approximately 7.5–8.5 J/cm² in the referenced protocols—compared with roughly 8.5–10 J/cm² in lighter skin, helping limit epidermal injury and dyspigmentation.
Fluence should be titrated to a reproducible clinical endpoint, with phototype used as a safety modifier rather than a fixed dosing rule. Darker skin generally warrants a more conservative starting approach, careful test spots, and longer recovery intervals because post-inflammatory hyperpigmentation and hypopigmentation are more consequential risks.
Why Fluence Must Be Individualized
Phototype changes the safety margin
Fitzpatrick IV–V skin contains more epidermal melanin, so the laser can unintentionally heat or fragment epidermal pigment in addition to targeting dermal melanocytes.
This narrows the therapeutic window. A fluence that produces appropriate whitening in lighter skin may cause excessive epidermal injury, crusting, pigment alteration, or prolonged inflammation in darker skin.
The numerical fluence is not universal
The approximate ranges of 7.5–8.5 J/cm² for darker phototypes and 8.5–10 J/cm² for lighter phototypes should be treated as protocol-specific reference points, not universal prescriptions.
Actual energy selection also depends on wavelength, spot size, pulse duration, device design, lesion depth, lesion color, and prior treatment response. Fluence should therefore be adjusted using both the device parameters and the observed tissue response.
Test spots improve control
A small test area is particularly valuable in phototypes IV–V, patients with a history of pigmentary complications, and previously treated lesions.
The clinician should assess the immediate response and delayed effects before treating the entire lesion. This approach is safer than applying a fixed fluence based solely on skin type.
Managing the Immediate Endpoint
Whitening is the primary endpoint
For Q-switched Ruby and Alexandrite systems, immediate tissue whitening is the standard endpoint. It reflects rapid pigment disruption and melanosome injury within the treated area.
Whitening should be immediate and reasonably uniform across the target, without requiring excessive epidermal trauma.
Nd:YAG responses require device-specific interpretation
With Q-switched 1064-nm Nd:YAG, some protocols describe immediate whitening with fine punctate bleeding as an endpoint. However, punctate bleeding should not be pursued automatically or treated as mandatory across all devices and patients.
It may indicate a more aggressive treatment response, but the acceptable endpoint depends on the laser platform, treatment technique, lesion depth, and the operator’s established protocol. In darker skin, deliberately escalating to bleeding may increase the risk of prolonged inflammation and pigmentary change.
Avoid using clinical darkness alone as the endpoint
A lesion may remain visibly pigmented immediately after treatment despite adequate dermal injury, particularly when pigment is deep or unevenly distributed.
Fluence should not be increased simply because complete visual clearance is not immediate. Clearance occurs progressively as fragmented pigment is removed by inflammatory and phagocytic processes.
Adjusting Treatment Across Skin Phototypes
Phototypes I–III
Lighter phototypes generally provide a wider margin between dermal pigment disruption and epidermal injury.
Within an appropriate device protocol, fluences around 8.5–10 J/cm² may produce immediate whitening. The clinician should still avoid escalating solely to accelerate clearance, because excessive energy can cause scarring, textural change, or focal hypopigmentation.
Phototypes IV–V
For darker skin, begin more conservatively and use the lowest fluence that produces the desired endpoint. The referenced range of approximately 7.5–8.5 J/cm² may achieve whitening while reducing unnecessary epidermal damage.
Monitor closely for delayed post-inflammatory hyperpigmentation, hypopigmentation, prolonged erythema, crusting, and textural change. Darker phototypes often require more cautious escalation, not necessarily fewer treatments.
Previously treated or pigment-altered skin
Prior laser exposure can change the tissue response and may reduce the predictability of a standard fluence.
If the area shows hypopigmentation, persistent erythema, crusting, or scarring, treatment should be deferred until recovery and reassessed rather than intensified.
Match Expectations to Lesion Characteristics
Brown lesions often clear faster
Brown Nevus of Ota lesions generally respond more rapidly than blue or blue-green lesions.
The reference describes approximately three treatments for many brown lesions, although the exact number varies with depth, density, and treatment interval.
Blue-green lesions usually need more sessions
Blue and green components indicate deeper or differently distributed dermal pigment and may require six or more sessions.
This is an important reason to avoid excessive fluence. A slower, staged treatment course is often safer than trying to force early clearance with higher energy.
Clearance is cumulative
Clinical improvement commonly continues over multiple sessions, with many studies reporting substantial lightening after approximately four to five treatments.
The number of sessions should be guided by residual pigment, endpoint reproducibility, and tissue recovery—not by a predetermined promise of complete clearance.
Plan Intervals Around Tissue Recovery
Start with moderate intervals
Initial sessions are commonly spaced six to eight weeks apart.
This allows acute inflammation and epidermal changes to resolve before the next exposure and provides time for fragmented dermal pigment to clear.
Lengthen intervals later
As the lesion becomes lighter, achieving the endpoint may require more careful fluence adjustment and the residual pigment may be more difficult to target uniformly.
At this stage, intervals may need to extend to several months, particularly when there is persistent inflammation or a history of pigmentary alteration.
Do not treat residual color too early
Residual pigmentation shortly after treatment does not necessarily represent treatment failure.
Premature retreatment can compound inflammation and increase the risk of post-inflammatory hyperpigmentation or hypopigmentation, especially in phototypes IV–V.
Understanding the Trade-offs
Higher fluence may not mean faster clearance
Increasing fluence can produce a stronger immediate response, but it also increases the risk of epidermal injury and dyspigmentation.
For Nevus of Ota, repeated treatments at an appropriate endpoint are generally more controllable than a single overly aggressive session.
More aggressive endpoints carry more risk
Punctate bleeding may be used in selected Nd:YAG protocols, but it represents a more traumatic endpoint than whitening alone.
It should be considered a device- and protocol-dependent finding rather than a universal treatment target, particularly in darker skin.
Pigment complications may be delayed
Post-inflammatory hyperpigmentation or hypopigmentation may develop after the immediate whitening has resolved.
Follow-up must therefore evaluate both the short-term endpoint and the delayed pigment response before deciding whether to increase fluence.
Complete clinical clearing may not mean complete cellular clearance
Deep dermal melanocytes may persist despite apparent clinical clearance.
Long-term follow-up is appropriate because recurrence or gradual repigmentation can occur when sublethally injured pigment cells remain.
How to Apply This to Treatment Planning
The safest approach is to combine phototype-based caution with endpoint-based titration and device-specific technique.
- If your primary focus is safety in Fitzpatrick IV–V skin: Start conservatively, commonly within the referenced 7.5–8.5 J/cm² range, use test spots, and stop at effective whitening rather than escalating toward unnecessary tissue trauma.
- If your primary focus is treatment efficacy in lighter skin: Fluences around 8.5–10 J/cm² may be appropriate within the selected device protocol, but they should still be adjusted to immediate whitening and delayed tissue response.
- If your primary focus is Nd:YAG treatment: Interpret whitening—and, where specifically established, limited punctate bleeding—according to the device protocol rather than treating bleeding as a mandatory endpoint.
- If your primary focus is reducing pigmentary complications: Space initial treatments by approximately 6–8 weeks, lengthen intervals as the lesion lightens, and avoid retreating before inflammation has resolved.
- If your primary focus is predicting the number of sessions: Expect brown lesions to respond faster, often around three treatments, while blue-green lesions may require six or more staged sessions.
The most reliable strategy is controlled, endpoint-driven treatment that prioritizes durable clearance without exceeding the skin’s pigmentary safety margin.
Summary Table:
| Phototype | Fluence Range (J/cm²) | Endpoint | Considerations |
|---|---|---|---|
| I–III | 8.5–10 | Immediate whitening | Wider safety margin; avoid over-treatment |
| IV–V | 7.5–8.5 | Immediate whitening | Conservative start; test spots essential; watch for PIH |
Enhance your practice with BELIS's advanced Q-switched laser systems. Our professional-grade devices are designed for optimal safety and efficacy across diverse skin types. Contact our experts today to learn how we can support your clinical success and patient satisfaction. Get in touch now!
Related Products
- Q Switch Nd Yag Laser Machine Tattoo Removal Nd Yag Machine
- Cryolipolysis Fat Freezing Cavitation Lipo Laser Machine
- Ultrasonic Cavitation Machine Lipo Laser Device
- Fractional CO2 Laser Machine for Skin Treatment
- Fractional CO2 Laser Machine for Skin Treatment
People Also Ask
- What is the documented effectiveness of Q-switched Nd:YAG lasers for tattoo removal? Gold Standard Results
- How does laser fluence influence pigment clearance vs. safety? Balancing Speed and Skin Integrity in Tattoo Removal
- What pigment compositions and particle properties should practitioners evaluate before operating Q-switched Nd:YAG lasers for tattoo removal? Evaluate pigment composition and particle size for safe, effective tattoo removal.
- How should aesthetic practitioners select wavelengths across Nd:YAG and Q-switched laser systems for target pigment depth and skin phototypes? Key Insights for Clinicians
- How should wavelength and fluence settings be adjusted on Nd:YAG and Q-switched lasers when treating darker skin tones? Optimize Safety & Efficacy
